ARCHIVES

FDA Committee IK IL-2/LAK For Modified Group C

This article is from The Cancer Letter archive.

Vol. 13 No. 18 | May 1, 1987

Download PDF Visit The Full Archive

Related Articles

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979

NCI To Hold Symposium To Honor Wener Kirsten

April 2, 1993

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007